Nova Ltd. (NVMI) exceeded $250 million in quarterly sales. Surpassing $250M quarterly sales marks strong revenue growth likely to lift future results and investor views.
| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | 1 | 4 | 4 | 1 | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 443.68 | 586.57 | 1,048.51 | 1,021.00 |
| Receivables | 111.26 | 139.32 | 151.93 | 210.28 |
| Inventory | 138.20 | 156.60 | 183.67 | 185.27 |
| Other | 17.08 | 19.47 | 26.69 | 36.31 |
| 710.22 | 901.95 | 1,410.80 | 1,452.86 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 35.16 | 59.58 | 46.98 | 66.78 |
| ST’ Debt | 197.68 | 180.56 | — | 733.59 |
| Other | 41.29 | 68.03 | 102.19 | 80.18 |
| 322.81 | 388.23 | 224.54 | 936.57 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 235.31 | 254.96 | — | — |
—
|
| ’25 | 213.36 | 219.99 | 224.61 | 222.62 |
880.58
|
| ’24 | 141.80 | 156.86 | 178.97 | 194.77 |
672.40
|
| ’23 | 132.19 | 122.70 | 128.81 | 134.22 |
517.92
|
| ’22 | 133.96 | 141.63 | 143.91 | 151.24 |
570.73
|
| ’21 | 84.13 | 97.75 | 112.71 | 121.52 |
416.11
|
| ’20 | 61.02 | 62.59 | 69.49 | 76.30 |
269.40
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 40.08 | 40.92 | — | — |
—
|
| ’25 | 68.55 | 45.66 | 71.28 | 60.13 |
245.61
|
| ’24 | 59.44 | 60.33 | 46.98 | 68.52 |
235.27
|
| ’23 | 23.07 | 24.17 | 46.69 | 29.61 |
123.53
|
| ’22 | 12.91 | 25.08 | 31.95 | 49.60 |
119.54
|
| ’21 | 32.99 | 26.38 | 52.63 | 20.26 |
132.26
|
| ’20 | 13.89 | 18.92 | 20.97 | 6.48 |
60.25
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 36.03 | 38.42 | — | — |
—
|
| ’25 | 59.69 | 42.92 | 66.94 | 48.36 |
217.92
|
| ’24 | 56.67 | 57.92 | 43.06 | 60.40 |
218.05
|
| ’23 | 20.31 | 20.89 | 43.13 | 22.00 |
106.34
|
| ’22 | 9.19 | 20.84 | 27.02 | 41.17 |
98.23
|
| ’21 | 32.50 | 25.07 | 51.87 | 18.01 |
127.45
|
| ’20 | 11.62 | 18.03 | 19.26 | 4.91 |
53.81
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2.04 | 2.20 | — | — |
—
|
| ’25 | 2.03 | 2.14 | 1.90 | 1.94 |
7.96
|
| ’24 | 1.15 | 1.41 | 1.60 | 1.58 |
5.75
|
| ’23 | 1.09 | 0.94 | 1.05 | 1.20 |
4.28
|
| ’22 | 1.07 | 1.09 | 1.10 | 1.14 |
4.40
|
| ’21 | 0.60 | 0.77 | 1.02 | 0.73 |
3.12
|
| ’20 | 0.41 | 0.30 | 0.48 | 0.47 |
1.65
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 67.40 | 81.91 | 128.74 | 154.00 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 149.15 | 138.50 | 247.21 | 361.32 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,531 | 3,606 | 4,149 | 1,612 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.16 | 0.14 | 0.16 | 0.55 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 570.73 | 517.92 | 672.40 | 880.58 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 55.54% | 56.61% | 57.57% | 57.37% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 158.41 | 154.70 | 216.29 | 303.29 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.76% | 29.87% | 32.17% | 34.44% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 140.21 | 136.31 | 183.76 | 259.22 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.60 | 14.48 | 11.48 | 18.62 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.89 | 17.97 | 23.10 | 29.25 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 4.89 | 4.73 | 6.31 | 8.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.17 | 4.29 | 8.08 | 8.16 | ‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.74) | (0.60) | (0.59) | (0.92) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.42 | 3.69 | 7.49 | 7.24 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.45 | 26.04 | 31.87 | 43.78 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.70 | 28.83 | 29.11 | 30.11 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.92 | 28.68 | 31.26 | 37.83 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.17 | 7.55 | 8.53 | 11.23 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.05 | 5.21 | 6.18 | 7.50 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.87 | 7.15 | 7.98 | 10.97 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.48 | 34.83 | 24.61 | 44.33 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 119.54 | 123.53 | 235.27 | 245.61 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (21.31) | (17.19) | (17.21) | (27.70) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 98.23 | 106.34 | 218.05 | 217.92 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 478.88 | 387.41 | 513.72 | 1,186.27 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 202.36 | 197.68 | 180.56 | 731.68 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (171.14) | (246.00) | (406.00) | (316.83) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 586.96 | 750.75 | 927.80 | 1,318.25 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.67% | 12.87% | 14.56% | 13.82% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.54% | 16.38% | 22.46% | 15.82% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26.44% | 20.38% | 21.90% | 23.08% | — | — | — |
ROE
|
Nova Ltd. (NVMI) is riding the semiconductor wave like few others, transforming from a $164 million revenue player in 2016 into a $672 million powerhouse by 2024—a blistering 20%+ CAGR fueled by precision metrology tools essential for AI chips, EUV lithography, and advanced packaging. This isn’t mere cycle-chasing; it’s a tale of scaling innovation amid Nvidia and TSMC’s node-shrinking frenzy, with employee headcount exploding 482% to over 4,000 and revenue per employee stabilizing at $162,000. Projections dazzle: $879 million in 2025 (31% growth), scaling to $1.23 billion by 2027, perfectly synced with the AI supercycle.
Profitability cements the story, with gross margins resilient at 57.6%, EBT margins soaring to 32%, and net income rocketing 1,806% to $184 million (EPS at $6.31). A fortress balance sheet boasts $928 million equity, net cash buffers, 22% ROIC, and $218 million free cash flow—primed for M&A or dividends amid disciplined capex. Stock highs hit $247 in 2024, with analysts eyeing 15%+ upside on 25% EPS growth forecasts to $11.80 by 2027.
Yet the real intrigue lies ahead: NVMI’s edge in high-NA EUV and AI-enhanced metrology positions it for disruptive leaps as India/SEA fabs rise and inference booms. Resilient through trade wars and COVID, with no insider drama, this profitable growth machine whispers “multibagger” for patient investors—dive into the full analysis for the charts and catalysts.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.